Surviving Mesothelioma Report: New Data Suggests That Multimodal Mesothelioma Treatment Can Be Effective, Even in Low-Volume Centers

Share Article

Italian doctors say their new study is a validation of this mesothelioma treatment protocol and of smaller medical centers that offer it.

Multimodal Mesothelioma Treatment Outcomes

Mesothelioma Treatment in a Low-Volume Center

...pleurectomy/decortication and HITHOC are a good therapeutic option in the multimodality treatment of malignant pleural mesothelioma.

An Italian medical center treating mesothelioma patients with pleurectomy/decortication (P/D) and heated intraoperative chemotherapy (HITHOC) is showing good outcomes and doctors there say it’s good news for patients and small centers like theirs. Surviving Mesothelioma has just posted an article on the new research study. Click here to read it now.

Researchers at Policlinico Hospital in Catania, Italy conducted a small study on six of their mesothelioma patients treated with P/D surgery and HITHOC. Study author Marcello Migliore says the results confirm the effectiveness of the protocol.

“This small experience confirms that pleurectomy/decortication and HITHOC are a good therapeutic option in the multimodality treatment of malignant pleural mesothelioma,” writes Dr. Migliore.

In contrast to previous studies suggesting that the P/D and HITHOC procedures should only be done in high volume centers, the new article in Future Oncology reports no deaths from the procedure and a mean mesothelioma survival of 21.5 months.

“If these results can be verified in larger studies, it is potentially very good news for pleural mesothelioma patients who do not live near a major medical center,” says Surviving Mesothelioma’s Managing Editor, Alex Strauss.

See the results of the Italian study and learn more about multimodality treatment for mesothelioma in Mesothelioma Treatment Outcomes in a Low Volume Center, now available on the Surviving Mesothelioma website.

Migliore, M, et al, “Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience”, November 2015, Future Oncology, pp. 19 - 22,

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website